Evidence map›Paper›PMID 30877750›Full record

ArticleThe journals of gerontology. Series B, Psychological sciences and social sciences2020

Hallucinations and Delusions Signal Alzheimer's Associated Cognitive Dysfunction More Strongly Compared to Other Neuropsychiatric Symptoms.

Joshua T Fuller, Tabina K Choudhury, Deborah A Lowe, Steve Balsis, Alzheimer’s Disease Neuroimaging Initiative

Open access · bronzeAbstract read
In one paragraph

Article in The journals of gerontology. Series B, Psychological sciences and social sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Increased retention of tau PET ligand [Translational psychiatry · 2022
    Article
  5. Validation of a Brief Multi-Dimensional Assessment of Dementia Severity.Journal of the American Geriatrics Society · 2021
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Joshua T FullerDepartment of Psychological and Brain Sciences, Boston University, Massachusetts.
Tabina K ChoudhuryDepartment of Psychological and Brain Sciences, Texas A&M University, College Station.
Deborah A LoweDepartment of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Oklahoma City.
Steve BalsisDepartment of Psychology, University of Massachusetts Lowell.
Alzheimer’s Disease Neuroimaging Initiative
Massachusetts General Hospital · USTexas A&M University · USUniversity of Massachusetts Lowell · USUniversity of Oklahoma Health Sciences Center · US

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

objectivesNeuropsychiatric symptoms (NPS) are common among individuals with dementia of the Alzheimer's type (DAT). We sought to characterize which NPS more purely relate to cognitive dysfunction in DAT, relative to other NPS.

methodDemographic, neurocognitive, neuroimaging, and NPS data were mined from the Alzheimer's Disease Neuroimaging Initiative database (n = 906). Using factor analysis, we analyzed the degree to which individual NPS were associated with DAT-associated cognitive dysfunction. We also employed item response theory to graphically depict the ability of individual NPS to index DAT-associated cognitive dysfunction across a continuum ranging from cognitively normal to mild DAT.

resultsPsychotic symptoms (hallucinations and delusions) were more strongly related to the continuum of DAT-associated cognitive dysfunction than other NPS, with the strength of the relationship peaking at high levels of disease severity. Psychotic symptoms also negatively correlated with brain volume and did not relate to the presence of vision problems. Aberrant motor behavior and apathy had relatively smaller associations with DAT-associated cognitive dysfunction, while other NPS showed minimal associations. DISCUSSION: Psychotic symptoms most strongly indexed DAT-associated cognitive dysfunction, whereas other NPS, such as depression and anxiety, were not as precisely related to the DAT-associated cognitive dysfunction.

Indexed as

Alzheimer DiseaseBrainCognitive DysfunctionDelusionsHallucinationsNeurocognitive DisordersNeuroimagingAgedCorrelation of DataDatabases, FactualFemaleHumansMaleMental Status and Dementia TestsOrgan SizePsychiatric Status Rating ScalesAlzheimer’s diseaseDementiaMild cognitive impairmentQuantitative methods

Identifiers

PMID30877750
PMCPMC7751129
OpenAlexW2922076665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.